|
JP2020143042A
|
|
Transdermal preparation
|
|
WO2020032159A1
|
|
Particulate composition and production method therefor
|
|
WO2020004393A1
|
|
Processing method for raw drug particles of non-uniform particle size
|
|
WO2019093434A1
|
|
Acetaminophen preparation, and method for producing same
|
|
JP2018162311A
|
|
Extract and formulation
|
|
JP2018177800A
|
|
Production method of premix drug substance
|
|
JP2018048129A
|
|
Agent for improving or treating erythromelalgia
|
|
JP2018043987A
|
|
Agent for improving or treating neurogenic bladder
|
|
JP2019031472A
|
|
tablet
|
|
CN109475557A
|
|
Thin membrane coated tablet containing methotrexate (MTX)
|
|
WO2017073738A1
|
|
Tablet having fexofenadine as effective component thereof
|
|
JP2016216518A
|
|
Extract and formulation containing the same
|
|
CN107922341A
|
|
The manufacture method of 4 new benzo azonine derivatives
|
|
JP2017014204A
|
|
Improvement or treatment agent of chondromalacia patella
|
|
KR20180108903A
|
|
Pluripotent stem cell migration promoter
|
|
JP2016199541A
|
|
Improving or therapeutic agent of zoster keratitis
|
|
JP2016094467A
|
|
Extract and formulation
|
|
JP2016033145A
|
|
Extract and formulation containing the same
|
|
JP2016027024A
|
|
Medicine comprising cinnamic acid amide derivative
|
|
US2017135985A1
|
|
Therapeutic/ preventive agent containing coumarin derivative as active ingredient
|
